Both, proapoptotic BCL-2 or MAP kinase pathway members (BIK, BAK1, MAP3K12, and MAPK9) and proliferation-associated tumor drivers (FOS, HOXA3, and POLR2B) had an increased gene expression. The gene discussed is MAPK9; the disease is neoplasm.